|Bid||7.25 x N/A|
|Ask||7.45 x N/A|
|Day's range||7.25 - 7.50|
|52-week range||3.84 - 13.70|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Shares of Exscientia (NASDAQ: EXAI) were up 30.3% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence. One reason for this week's share growth was the company's first-quarter earnings report. When chipmaker Nvidia posted strong earnings on the back of AI growth, that helped lift other AI-associated stocks such as Exscientia, which uses AI to help it discover oncology therapies, frequently partnering with larger pharmaceutical companies.
With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede.
Key Insights The considerable ownership by retail investors in Exscientia indicates that they collectively have a...
Exscientia ( NASDAQ:EXAI ) Full Year 2022 Results Key Financial Results Revenue: UK£27.2m (flat on FY 2021). Net loss...
Exscientia plc ( NASDAQ:EXAI ) shareholders should be happy to see the share price up 27% in the last quarter. But...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Exscientia PLC Sponsored ADR (EXAI) delivered earnings and revenue surprises of -72.73% and 47.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
A look at the shareholders of Exscientia plc ( NASDAQ:EXAI ) can tell us which group is most powerful. With 57% stake...
Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of 12.50% and 11.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Exscientia plc ( NASDAQ:EXAI ) shareholders should be happy to see the share price up 12% in the last week. But that's...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
The average of price targets set by Wall Street analysts indicates a potential upside of 62.6% in Exscientia PLC Sponsored ADR (EXAI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.